Literature DB >> 23140

Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice.

L Mussoni, A Poggi, G De Gaetano, M B Donati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 23140      PMCID： PMC2009508          DOI： 10.1038/bjc.1978.18

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  14 in total

1.  Ditazole and platelets III. Effect of ditazole on tumor-cell induced thrombocytopenia and on bleeding time in mice.

Authors:  L Mussoni; A Poggi; M B Donati; G de Gaetano
Journal:  Haemostasis       Date:  1977

Review 2.  Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants.

Authors:  S Wood
Journal:  J Med       Date:  1974

3.  Anti-metastatic effect of aspirin.

Authors:  G J Gasic; T B Gasic; S Murphy
Journal:  Lancet       Date:  1972-10-28       Impact factor: 79.321

4.  Haematological effects of aspirin.

Authors:  J J Kolenich; E G Mansour; A Flynn
Journal:  Lancet       Date:  1972-09-30       Impact factor: 79.321

5.  Antimetastatic effects associated with platelet reduction.

Authors:  G J Gasic; T B Gasic; C C Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

6.  Release of prostaglandin F1alpha and F2alpha from superfused platelets: quantitative evaluation of the inhibitory effects of some aspirin-like drugs.

Authors:  C Patrono; G Ciabattoni; D Crossi-Belloni
Journal:  Prostaglandins       Date:  1975-04

7.  The effects of an antimetastatic agent, (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior.

Authors:  A Atherton; D Busfield; K Hellman
Journal:  Cancer Res       Date:  1975-04       Impact factor: 12.701

8.  On thrombocytopenia developing in mice bearing a spontaneously metastasizing tumor.

Authors:  A Poggi; M B Donati; N Polentarutti; G de Gaetano; S Garattini
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30

9.  The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL).

Authors:  P Hilgard; H Heller; C G Schmidt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30

10.  The role of blood platelets in experimental metastases.

Authors:  P Hilgard
Journal:  Br J Cancer       Date:  1973-11       Impact factor: 7.640
View more
  7 in total

Review 1.  Role of plasma, platelets, and endothelial cells in tumor metastasis.

Authors:  G J Gasic
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 2.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

3.  Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis.

Authors:  T Tsuruo; H Kawabata; H Iida; T Yamori
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

4.  Improved Synthesis of Anxiolytic, Anticonvulsant and Antinociceptive α2/α3-GABA(A)ergic Receptor Subtype Selective Ligands as Promising Agents to Treat Anxiety, Epilepsy, as well as Neuropathic Pain.

Authors:  Guanguan Li; Lalit K Golani; Rajwana Jahan; Farjana Rashid; James M Cook
Journal:  Synthesis (Stuttg)       Date:  2018-10       Impact factor: 3.157

5.  Inhibition of spontaneous and experimental tumor metastasis by the calcium antagonist verapamil.

Authors:  T Tsuruo; H Iida; F Makishima; T Yamori; H Kawabata; S Tsukagoshi; Y Sakurai
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences.

Authors:  I Saiki; J Murata; J Iida; T Sakurai; N Nishi; K Matsuno; I Azuma
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

7.  Design, synthesis and biological evaluation of 3-(2-aminooxazol-5-yl)-2H-chromen-2-one derivatives.

Authors:  Saloni Kakkar; Sanjiv Kumar; Siong Meng Lim; Kalavathy Ramasamy; Vasudevan Mani; Syed Adnan Ali Shah; Balasubramanian Narasimhan
Journal:  Chem Cent J       Date:  2018-12-04       Impact factor: 4.215
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.